UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549-1004
 
FORM 8-K

CURRENT REPORT

PURSUANT TO SECTION 13 OR 15(d) OF
THE SECURITIES EXCHANGE ACT OF 1934
 
Date of report (Date of earliest event reported):  January 8, 2014
Merge Healthcare Incorporated
(Exact name of registrant as specified in its charter)
 
Delaware
001–33006
39-1600938
(State of incorporation)
(Commission File Number)
(I.R.S Employer Identification No.)
 
 
 
 350 North Orleans Street, 1st Floor
 
 
Chicago, Illinois
 
60654
 (Address of Principal Executive Offices)
 
(ZIP Code) 

(312) 565-6868
(Registrant’s telephone number, including area code)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

o
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

o
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17-CFR 240.14a-12)

o
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

o
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
 
Item 8.01
Other Events.
 
On January 8, 2014, Merge Healthcare Incorporated (the “Company”) issued a News Release containing information about a revision of the Company’s previously-announced subscription backlog totals.

A copy of the Company’s News Release is included as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated herein by reference.
 
Item 9.01
Financial Statements and Exhibits.
 
News Release of the Company dated January 8, 2014

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 
MERGE HEALTHCARE INCORPORATED
 
(Registrant)
 
 
 
Date:  January 8, 2014
By:
/s/ Justin C. Dearborn
 
Name:
Justin C. Dearborn
 
Title:
Chief Executive Officer